Rubius Therapeutics Reports Second Quarter 2019 Financial Results and Operational Progress

NEXT STORY
Vaccinex Announces Full Enrollment Achieved in Ongoing CLASSICAL-Lung Phase 1b/2 Trial of Pepinemab in Combination with BAVENCIO® (avelumab) in Advanced Non-Small Cell Lung Cancer
PREV STORY
Dehydration Monitoring Systems Market to grow at 9.6% CAGR during (2019-2025) Insights on Key Trends, Technological Development, Growth Drivers, Top Players, and Business Opportunities: Adroit Market Research
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

MediWound Launches EscharEx® U.S. Clinical Development Program

author_avatar
NASDAQ Market News

Global Disinfectants Industry

author_avatar
NASDAQ Market News

EyePoint Pharmaceuticals Signs Exclusive License Agreement with Equinox Science to Develop Tyrosine Kinase Inhibitor Vorolanib for the Treatment of Wet AMD, Diabetic Retinopathy and Retinal Vein Occlusion

author_avatar
NASDAQ Market News